Cuenca-Estrella M, Arendrup M C, Chryssanthou E, Dannaoui E, Lass-Florl C, Sandven P, Velegraki A, Rodriguez-Tudela J L
National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Clin Microbiol Infect. 2007 Oct;13(10):1018-22. doi: 10.1111/j.1469-0691.2007.01790.x. Epub 2007 Aug 13.
A multicentre study involving seven laboratories was performed using techniques recommended by the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) to evaluate and propose quality control ranges and strains for susceptibility testing of fermentative yeasts and filamentous fungi. Participating laboratories tested the susceptibilities of a panel of 12 encoded isolates to amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole. In total, 15 lots of assay medium were tested, with one lot being common to all laboratories, and 18 144 MIC values were determined. Intra- and inter-laboratory agreements and intra-class correlation coefficients (ICCs) of the results for each drug/strain/lot combination were calculated. An average value of 85% agreement was selected for validation purposes. The average percentage of intra-laboratory agreement was 90-95%, with ICC values of 0.90-0.95 (p <0.01). Inter-laboratory reproducibility was also high, with 92% agreement and an ICC of 0.97 (p <0.01). The reproducibility was somewhat better with the common lot of assay medium (96% agreement) than with the different lots (91% agreement), but this difference was not significant. Two isolates that showed trailing growth had agreement percentages below the 85% limit selected for validation purposes and were therefore excluded from the panel of quality control strains. The recommended EUCAST methodologies were found to be highly reproducible and reliable for susceptibility testing of yeasts and filamentous fungi. Ten isolates are proposed for use as quality control strains with these EUCAST procedures.
一项涉及七个实验室的多中心研究采用了欧洲抗菌药物敏感性测试委员会抗真菌药敏试验小组委员会(AFST-EUCAST)推荐的技术,以评估并提出发酵酵母和丝状真菌药敏试验的质量控制范围及菌株。参与研究的实验室检测了一组12种编码菌株对两性霉素B、氟胞嘧啶、氟康唑、伊曲康唑、伏立康唑和泊沙康唑的敏感性。总共测试了15批测定培养基,其中一批为所有实验室通用,共测定了18144个最低抑菌浓度(MIC)值。计算了每种药物/菌株/批次组合结果的实验室内和实验室间一致性以及组内相关系数(ICC)。为验证目的选择了85%的平均一致性值。实验室内一致性的平均百分比为90%-95%,ICC值为0.90-0.95(p<0.01)。实验室间的重现性也很高,一致性为92%,ICC为0.97(p<0.01)。通用批次的测定培养基的重现性(一致性96%)比不同批次(一致性91%)稍好,但这种差异不显著。有两个显示拖尾生长的菌株的一致性百分比低于为验证目的选择的85%的限值,因此被排除在质量控制菌株组之外。发现推荐的EUCAST方法在酵母和丝状真菌的药敏试验中具有高度的重现性和可靠性。建议将十种菌株用作这些EUCAST程序的质量控制菌株。